Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
About this episode
This episode discusses how tumor-agnostic therapies are transforming cancer treatment pathways.
Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu
Topics covered
- precision oncology
- tumor-agnostic therapies
- cancer treatment
- biomarkers
- healthcare pathways
Keywords
- precision oncology
- tumor-agnostic
- biomarkers
- cancer treatment
- healthcare
Mentioned in this episode
Organizations: Medscape Podcasts
Books & works: Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
More episodes of Keeping Current
- Pharmacological and Combination Interventions for Nicotine Cessation
- Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
- The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
- Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
- Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes
Explore listener stats, chart rankings, contacts and more on the Keeping Current podcast page.